D68.3 - Hemorrhagic disorder due to circulating anticoagulants
D68.31 - Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
D68.318 - Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
InclusionTerm:
-Antithromboplastinemia
-Antithromboplastinogenemia
-Hemorrhagic disorder due to intrinsic increase in antithrombin
-Hemorrhagic disorder due to intrinsic increase in anti-VIIIa
-Hemorrhagic disorder due to intrinsic increase in anti-IXa
-Hemorrhagic disorder due to intrinsic increase in anti-XIa